Ryohei Ohtani, Masahiro Mori, Akiyuki Uzawa, Tomohiko Uchida, Jia Liu, Hiroki Masuda, Satoshi Kuwabara (Department of Neurology, Graduate School of Medicine, Chiba University, Japan)

Kimitoshi Kimura^1,2, Youwei Lin^1,3,4, Wakiro Sato^1,3, Ryosuke Takahashi², Takashi Yamamura^1,3 (1.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Japan, 2.Department of Neurology, Kyoto University Graduate School of Medicine, Japan, 3.Multiple Sclerosis Center, National Center Hospital, NCNP, Japan, 4.Department of Neurology, National Center Hospital, NCNP, Japan)

Yuko Shimizu, Ryotaro Ikeguchi, Haruka Kojima, Hayato So, Kazuo Kitagawa (Department of Neurology Tokyo Women's Medical University School of Medicine, Japan)

Shuhei Nishiyama¹, Tatsuro Misu¹, Yoshiki Takai¹, Hiroshi Kuroda¹, Ichiro Nakashima², Kazuo Fujihara³, Masashi Aoki¹ (1.Department of neurology, Tohoku University school of medicine, Japan, 2.Department of neurology, Tohoku Pharmaceutical University school of medicine, 3.Department of multiple sclerosis therapeutics, Fukushima medical university school of medicine)

Tomoko Okamoto¹, Youwei Lin^1,2, Manabu Araki^1,2, Wakiro Sato², Yuji Takahashi¹, Takashi Yamamura² (1.Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Japan, 2.Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry)